Role of CT Scan for the Successful Recanalization of Chronic Total Occlusion; a Randomized Comparison Between 3D CT-guided PCI vs. Conventional Treatment (CT-CTO Trial)

Last updated: January 21, 2020
Sponsor: Yonsei University
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT02037698
1-2013-0062
  • Ages > 20
  • All Genders

Study Summary

The revascularization of chronic total occlusion of coronary arteries (CTO) is the most challenging procedure for the coronary intervention. For the initial period for CTO intervention, percutaneous coronary artery intervention (PCI) of CTO lesions are associated with low procedural success rates about 70%. Recently, the success rate of the recanalization of CTOs has been raised in several studies.

Coronary CT angiography (CCTA) is an effective noninvasive diagnostic modality for detecting coronary artery disease. CCTA can visualize the complete anatomy of coronary arteries in contrast to conventional coronary angiography, reducing the deferral rates from CTO intervention. Assessment of characteristics of CTO lesions by pre-procedural CCTA could help to determine revascularization strategy and estimate the procedure time, leading to lower procedural complications. We suggest that success rates and clinical outcome of intervention of CTO lesion can be improved by pre-procedural CCTA.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients (age >19 years) with CTO (TIMI = 0 and estimated duration of occlusion atleast 3 months)

  • Typical symptomatic angina or positive stress test in various functional studiesevaluating ischemia

  • Eligible patients for pre-procedural CT scan and coronary angiogram

Exclusion

Exclusion Criteria:

  • Cardiogenic shock or ejection fraction < 25%

  • CTO lesions at DES restenosis or graft occlusion lesion

  • Significant left main stenosis

  • Retry of same CTO lesion within 2 weeks

  • Acute myocardial infarction within 48 hours

  • Hypersensitivity to aspirin, clopidogrel, or -limus families / or contraindication toantiplatelet agents

  • Severe hepatic dysfunction (≥3 times normal reference values)

  • Life expectancy < 1 years

  • Pregnant women or women with potential childbearing

Study Design

Total Participants: 400
Study Start date:
January 01, 2014
Estimated Completion Date:
December 31, 2020

Connect with a study center

  • Division of Cardiology, Severance Cardiovascular Hospital

    Seoul, 120-752
    Korea, Republic of

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.